These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 10905460)
21. Preparation and in vitro properties of N-succinylchitosan- or carboxymethylchitin-mitomycin C conjugate microparticles with specified size. Onishi H; Takahashi H; Yoshiyasu M; Machida Y Drug Dev Ind Pharm; 2001 Aug; 27(7):659-67. PubMed ID: 11694013 [TBL] [Abstract][Full Text] [Related]
22. Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. Jameela SR; Jayakrishnan A Biomaterials; 1995 Jul; 16(10):769-75. PubMed ID: 7492707 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of process parameters involved in chitosan microsphere preparation by the o/w/o multiple emulsion method. Pavanetto F; Perugini P; Conti B; Modena T; Genta I J Microencapsul; 1996; 13(6):679-88. PubMed ID: 8933353 [TBL] [Abstract][Full Text] [Related]
25. [Research on carboxymethyl chitosan acting as the adjuvant for implantable degradable microspheres]. Yin C; Hou C; Jiang L; Gu Q Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):350-4. PubMed ID: 15250131 [TBL] [Abstract][Full Text] [Related]
26. Chitin-based fast responsive pH sensitive microspheres for controlled drug release. Shang Y; Ding F; Xiao L; Deng H; Du Y; Shi X Carbohydr Polym; 2014 Feb; 102():413-8. PubMed ID: 24507299 [TBL] [Abstract][Full Text] [Related]
27. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin. Nishioka Y; Kyotani S; Okamura M; Miyazaki M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2871-3. PubMed ID: 2076575 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and biodegradation mechanisms of a versatile carboxymethyl derivative of chitosan in rats: in vivo and in vitro evaluation. Dong W; Han B; Feng Y; Song F; Chang J; Jiang H; Tang Y; Liu W Biomacromolecules; 2010 Jun; 11(6):1527-33. PubMed ID: 20459052 [TBL] [Abstract][Full Text] [Related]
29. Preparation and evaluation of chitosan microspheres containing bisphosphonates. Patashnik S; Rabinovich L; Golomb G J Drug Target; 1997; 4(6):371-80. PubMed ID: 9239577 [TBL] [Abstract][Full Text] [Related]
31. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery. Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101 [TBL] [Abstract][Full Text] [Related]
32. Preparation and evaluation of once-a-day injectable microspheres of interferon alpha in rats. Yoshikawa Y; Komuta Y; Nishihara T; Itoh Y; Yoshikawa H; Takada K J Drug Target; 1999; 6(6):449-61. PubMed ID: 10937290 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethyl-chitin. Song Y; Onishi H; Nagai T Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2822-5. PubMed ID: 1464115 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic study of taxol-loaded poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate after targeted delivery to the lung in mice. Sato H; Wang YM; Adachi I; Horikoshi I Biol Pharm Bull; 1996 Dec; 19(12):1596-601. PubMed ID: 8996646 [TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of melatonin-loaded stearyl alcohol microspheres. Lee BJ; Choe JS; Kim CK J Microencapsul; 1998; 15(6):775-87. PubMed ID: 9818955 [TBL] [Abstract][Full Text] [Related]
36. Controlled release of interleukin-2 from chitosan microspheres. Ozbaş-Turan S; Akbuğa J; Aral C J Pharm Sci; 2002 May; 91(5):1245-51. PubMed ID: 11977100 [TBL] [Abstract][Full Text] [Related]
37. Effect of multiporous microspheres derived from chitin and partially deacetylated chitin on the activation of mouse peritoneal macrophages. Nishimura K; Nishimura S; Seo H; Nishi N; Tokura S; Azuma I Vaccine; 1987 Jun; 5(2):136-40. PubMed ID: 3496721 [TBL] [Abstract][Full Text] [Related]
38. A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: effects of particle size and dose on chitin-containing cis-diamminedichloroplatinum(II) albumin microsphere antitumor activity in VX2 hepatic tumor model rabbits. Nishioka Y; Kyotani S; Okamura M; Ohnishi S; Yamamoto Y; Kawashima Y; Tanada S; Nakamura T Biol Pharm Bull; 1994 Sep; 17(9):1251-5. PubMed ID: 7841948 [TBL] [Abstract][Full Text] [Related]
39. Preparation and stability of liposome-type artificial red blood cells stabilized with carboxymethylchitin. Kato A; Arakawa M; Kondo T J Microencapsul; 1984; 1(2):105-12. PubMed ID: 6336519 [TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo evaluation of sustained release chitosan-coated ketoprofen microparticles. Yamada T; Onishi H; Machida Y Yakugaku Zasshi; 2001 Mar; 121(3):239-45. PubMed ID: 11265119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]